Vuja De Sciences Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

Vuja De Sciences General Information

Description

Developer of cancer metastasis treatments designed to prevent the recurrence and spread of cancer. The company offers laboratory technologies and integrates comparative oncology for vulnerabilities of undetected microscopic tumours, utilizing a proprietary combination of drugs that disrupt their survival mechanisms, enabling oncology and canine patients to address significant unmet medical needs in cancer treatment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 827 Bloomfield Street
  • Unit 300
  • Hoboken, NJ 07030
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 827 Bloomfield Street
  • Unit 300
  • Hoboken, NJ 07030
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vuja De Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 28-Jul-2025 Completed Generating Revenue
2. Later Stage VC 30-Oct-2023 Completed Clinical Trials - Phase 2
1. Later Stage VC (Series A) 29-Nov-2022 $2.98M $2.98M Completed Clinical Trials - Phase 2
To view Vuja De Sciences’s complete valuation and funding history, request access »

Vuja De Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer metastasis treatments designed to prevent the recurrence and spread of cancer. The company offers la
Drug Discovery
Hoboken, NJ
7 As of 2024

Philadelphia, PA
 

Madison, WI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vuja De Sciences Competitors (102)

One of Vuja De Sciences’s 102 competitors is Aro Biotherapeutics, a Venture Capital-Backed company based in Philadelphia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aro Biotherapeutics Venture Capital-Backed Philadelphia, PA
Centrose Venture Capital-Backed Madison, WI
Volastra Venture Capital-Backed New York, NY
Repertoire Immune Medicines Venture Capital-Backed Cambridge, MA
HiberCell Venture Capital-Backed Roseville, MN
You’re viewing 5 of 102 competitors. Get the full list »

Vuja De Sciences Patents

Vuja De Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023220082-A1 Methods, compositions, and combinations for preventing or treating cancer recurrence Pending 18-Feb-2022
EP-4479745-A2 Methods, compositions, and combinations for preventing or treating cancer recurrence Pending 18-Feb-2022
EP-4479745-A4 Methods, compositions, and combinations for preventing or treating cancer recurrence Pending 18-Feb-2022
US-20250161287-A1 Methods, compositions, and combinations for preventing or treating cancer recurrence Pending 18-Feb-2022
WO-2023158783-A2 Methods, compositions, and combinations for preventing or treating cancer recurrence Inactive 18-Feb-2022 A61K31/4545
To view Vuja De Sciences’s complete patent history, request access »

Vuja De Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vuja De Sciences FAQs

  • When was Vuja De Sciences founded?

    Vuja De Sciences was founded in 2017.

  • Where is Vuja De Sciences headquartered?

    Vuja De Sciences is headquartered in Hoboken, NJ.

  • What is the size of Vuja De Sciences?

    Vuja De Sciences has 7 total employees.

  • What industry is Vuja De Sciences in?

    Vuja De Sciences’s primary industry is Drug Discovery.

  • Is Vuja De Sciences a private or public company?

    Vuja De Sciences is a Private company.

  • What is Vuja De Sciences’s current revenue?

    The current revenue for Vuja De Sciences is .

  • How much funding has Vuja De Sciences raised over time?

    Vuja De Sciences has raised $4.05M.

  • Who are Vuja De Sciences’s competitors?

    Aro Biotherapeutics, Centrose, Volastra, Repertoire Immune Medicines, and HiberCell are some of the 102 competitors of Vuja De Sciences.

  • When was Vuja De Sciences acquired?

    Vuja De Sciences was acquired on 28-Jul-2025.

  • Who acquired Vuja De Sciences?

    Vuja De Sciences was acquired by Healx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process